Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate and Modafinil for Cognitive Function in Brain Tumor Patients
NCT00418691Phase 3Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 2004
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of modafinil, methylphenidate hydrochloride extended-release chewable tablet in cognitive impairment, sponsored by University of Texas MD Anderson Cancer Center. Started Feb 2004; status: terminated.
02
Drugs
modafinilmethylphenidate hydrochloride extended-release chewable tablet
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT00418691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00418691.